Navigation Links
Ethnic differences found for fatty liver disease and insulin resistance
Date:2/25/2009

A new study suggests that the metabolic response to obesity and insulin resistance, particularly as it pertains to the liver, differs among ethnic groups in the U.S. African-Americans are more resistant to the buildup of fat in the abdominal adipose tissue and liver, and to high triglyceride levels associated with insulin resistance. These findings are in the March issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience (www.interscience.wiley.com).

The abnormal accumulation of fat in the liver is related to obesity and is widely prevalent in the U.S. It is related to 20 percent of all newly diagnosed cases of chronic liver disease, which can progress and become life-threatening.

Previous studies have reported significant differences by ethnicity in the prevalence of non-alcoholic fatty liver disease (NAFLD). They have also suggested that African-Americans with NAFLD tend not to develop more serious liver disease. The reasons are unknown, but may help determine which individuals are at risk for NAFLD development and progression.

Researchers led by Jeffrey Browning of the University of Texas Southwestern Medical Center in Dallas sought to examine the issue in a large population-based study. They included 2170 African-American, Hispanic and Caucasian participants and examined metabolic factors for each, including total/regional adiposity, insulin resistance, and hypertriglyceridemia. They also measured each patient's levels of liver fat. They sought to understand how ethnic differences affect the interplay of all of these factors.

The researchers took blood samples from each patient to establish their level of insulin resistance. They then used proton magnetic resonance spectroscopy, dual energy x-ray absorptiometry and multi-slice abdominal MR imaging to determine each patient's hepatic triglyceride contant (HTGC) and fat distribution throughout the body.

They found that there was a close association between intraperitoneal fat and liver fat regardless of ethnicity. "Controlling for intraperitoneal fat content almost entirely eliminated ethnic differences in levels of HTGC and prevalence of hepatic steatosis," they report. "This was not the case with insulin resistance, total adiposity or other fat depots."

Interestingly, they found that the metabolic response to obesity and insulin resistance differed in African-Americans when compared to Hispanics and Caucasions. African-Americans appeared to be more resistant to the buildup of triglycerides in the abdominal visceral compartment and also to high triglyceride levels associated with insulin resistance.

They suggest that there is an insulin resistance phenotype. It could be a function of the organ that primarily contributes to lower insulin sensitivity. Or, it could be a function of the body's ability to expand subcutaneous fat in response to overnutrition. "Further study is needed to establish the basis for this insulin resistance paradox," they write.


'/>"/>

Contact: Sean Wagner
medicalnews@bos.blackwellpublishing.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Study finds race and ethnicity affect use of hospice services among patients with advanced cancer
2. NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis
3. Money motivates doctors to reduce ethnic differences in heart disease treatments
4. Easy Ethnic Election
5. Racial and ethnic disparities detected in patient experiences
6. Rice political scientists co-author report on ethnic/racial aspects of Taser use by Houston police
7. Latest CDC Report on HIV Incidence Grossly Excludes Hispanics in 2006, the Fastest Growing Ethnic Population in the United States and its Territories
8. New Study Shows Facial Plastic Surgery Helps African American's Perserve Ethnicity
9. Sleep problems associated with menopause vary among ethnic groups
10. USC study finds sex, age and ethnicity assciated with colorectal cancer survival
11. Womens Dermatologic Society Announces Collaboration on Americas Ethnic Skin: An Al Roker Health Special
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... 2017 , ... Miro is the ultimate smart media center that offers a ... TV shows and much more apps for user exploration. Its innovative acoustic design with ... 1280 x 720 provides crisp images with remarkable clarity and color. The WiFi connection ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is ... the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 ... 17025:2005 is the globally recognised standard that sets out requirements for the technical ...
(Date:2/26/2017)... ... 2017 , ... IndustryArchive.Org . is announcing a new way for B2B ... now only pay for B.A.N.T. quality sales leads based on the Sellers decision to ... new reality that B2B buyers are controlling the sales process via the Internet and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017   Royal Philips (NYSE: ... leader in health technology, today announced 510(k) clearance ... to market its ElastQ Imaging capability, further expanding ... systems. ElastQ Imaging enables simultaneous imaging of tissue ... for the diagnosis of various liver conditions. With ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. ... drug development company focused on tissue protection, repair ... RGN-137, GtreeBNT Co., Ltd., received a positive response ... clinical trial design for RGN-137 to treat epidermolysis ... gel that incorporates Thymosin beta 4 ("Tß4") as ...
(Date:2/27/2017)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced ... President and Chief Executive Officer (CEO) and member of the ... Richard Love , interim President and CEO who will ... Craig has over 20 years of experience in hematology, oncology ... Europe . "On behalf of CTI BioPharma,s ...
Breaking Medicine Technology: